• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconDrugs

Drugs

Page 7 of 30
HealthBinge drinking is on the rise among older adults. Here’s why it’s more dangerous and how to spot the signs
By Alexa MikhailNovember 3, 2024
RetailBritish pharma giant GSK reports a Q3 loss due to Zantac cancer lawsuits—but CEO Emma Walmsley remains optimistic on delivering 2024 guidance
By AFPOctober 30, 2024
HealthTop aging expert says these 4 FDA-approved drugs hold promise for extending life
By Alexa MikhailOctober 29, 2024
Diddy wearing a pair of sunglasses
LifestyleThe jail where Diddy and Sam Bankman-Fried reside is now the target of a federal clean-up operation because it’s so dangerous there
By Michael Balsamo, Michael R. Sisak and The Associated PressOctober 28, 2024
TechOlympus shares plunge after its CEO resigns over alleged illegal drug purchases
By AFPOctober 28, 2024
Anne Wojcicki, chief executive officer and co-founder of 23andMe
Leadership23andMe’s entire board resigned on the same day. Founder Anne Wojcicki still thinks the startup is savable
By Lila MacLellanOctober 17, 2024
RetailFrance’s top-selling painkiller may be sold to the U.S. and is causing the nation a splitting headache
By Jurgen Hecker and AFPOctober 15, 2024
Despite the ubiquitousness of injectable GLP-1 drugs indicated for people with obesity, most Americans wouldn’t take them, according to a September 2024 survey from the Physicians Committee for Responsible Medicine.
HealthMost Americans who want to lose weight don’t want to take GLP-1 drugs like Wegovy and Zepbound, new survey says
By Lindsey LeakeOctober 10, 2024
Martin Shkreli holds his head, as if he knows how much of a headache it's going to be to convince the Supreme Court to overturn his case
PoliticsMartin Shkreli gets snubbed by the Supreme Court and must return millions he reaped from jacking up the price of a lifesaving drug
By Lindsay Whitehurst and The Associated PressOctober 7, 2024
Albert Bourla puts his palm flat on tup of his other hand, rolled up in a fist, as he sits and listens to a question onstage at a conference.
FinancePfizer stock surges 3% after activist Starboard takes $1 billion stake, taps former execs
By Greg McKennaOctober 7, 2024
A woman voting
HealthProtecting Medicare a top concern for more than half of Americans in 2024 presidential election
By Lindsey LeakeOctober 1, 2024
FinanceCVS Health shares rise as hedge fund pushes for change
By Greg McKennaSeptember 30, 2024
Sam Altman, chief executive officer of OpenAI, is seen throwing a peace sign while driving a golf cart.
LeadershipSam Altman says taking psychedelics ‘significantly changed’ his mindset
By Chloe BergerSeptember 25, 2024
A person holds up a box of Ozempic.
HealthOzempic may help manage opioid addiction: study
By Naomi Kresge and BloombergSeptember 25, 2024
Lars Fruergaard Jorgensen, chief executive officer Novo Nordisk A/S, during an interview at the company's headquarters in Bagsvaerd, Denmark, on Monday, June 12, 2023.
HealthNovo Nordisk CEO takes aim at U.S. healthcare as he defends Ozempic pricing to Bernie Sanders
By Ryan HoggSeptember 24, 2024
1...
  • 5
  • 6
  • 7
  • 8
  • 9
...30
Most Popular
AI
A man let ChatGPT sell his home. It beat every agent's estimate by $100K—and closed in 5 daysAn image of a popular article
By Fortune EditorsMarch 21, 2026
Success
Covid gave us hybrid work. The Iran War might give us a four-day week—and this time, experts say it could stickAn image of a popular article
By Fortune EditorsMarch 21, 2026
Real Estate
Gen Z can’t afford a house. Some parents are choosing to fund their down payments over their college fundsAn image of a popular article
By Fortune EditorsMarch 20, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.